Arvinas's average Accounts Receivable for the
three
months ended in Dec. 2023 was $15.70 Mil. Arvinas's Revenue for the
three
months ended in Dec. 2023 was $-43.10 Mil.
The historical rank and industry rank for Arvinas's Days Sales Outstanding or its related term are showing as below:
ARVN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.65 Med: 23.56 Max: 1203.98
Current: 20.69
During the past 8 years, Arvinas's highest Days Sales Outstanding was 1203.98. The lowest was 4.65. And the median was 23.56.
ARVN's Days Sales Outstanding is ranked better than 90.58% of 892
companies
in the Biotechnology industry
Industry Median: 72.245
vs ARVN: 20.69
Arvinas's Days Sales Outstanding
declined
from Dec. 2022 (2.41) to Dec. 2023 (0.00).
Arvinas Days Sales Outstanding Historical Data
The historical data trend for Arvinas's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Arvinas's Days Sales Outstanding
For the Biotechnology subindustry, Arvinas's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvinas's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arvinas's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Arvinas's Days Sales Outstanding falls into.
Arvinas Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvinas (NAS:ARVN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Arvinas Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Arvinas's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARVN has been successfully added to your 